New Enterprise Associates 16 is a Venture Capital Fund in Maryland with $4.24 bn assets under management, with a minimum investment of $50.00 k. It has 239 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$4.24 bn
Address
New Enterprise Associates 16
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD 21093
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD 21093
Phone
410-842-4000
Ownership
Fund structure | AUM | Fund type |
---|---|---|
New Enterprise Associates | $27.00 bn | |
Nea 15 Opportunity Fund, L.P. | $828.28 mm | Venture Capital Fund |
Nea 18 Venture Growth Equity, L.P. | $574.95 mm | Venture Capital Fund |
Nea BH SPV II, L.P. | $10.39 mm | Venture Capital Fund |
Nea BH SPV, L.P. | $27.11 mm | Venture Capital Fund |
Nea Presidents Fund, L.P. | $192.53 k | Venture Capital Fund |
New Enterprise Associates 10, Limited Partnership | $213.62 mm | Venture Capital Fund |
New Enterprise Associates 11, Limited Partnership | $175.40 mm | Venture Capital Fund |
New Enterprise Associates 12, Limited Partnership | $327.72 mm | Venture Capital Fund |
Presidents Fund II, L.P. | ||
New Enterprise Associates 13, L.P. | $914.47 mm | Venture Capital Fund |
Presidents Fund III, L.P. | ||
New Enterprise Associates 14, L.P. | $5.88 bn | Venture Capital Fund |
Nea 14 Manager Fund, L.P. | ||
New Enterprise Associates 15, L.P. | $3.82 bn | Venture Capital Fund |
New Enterprise Associates 16, L.P. | $4.24 bn | Venture Capital Fund |
New Enterprise Associates 17, L.P. | $3.06 bn | Venture Capital Fund |
New Enterprise Associates 18, L.P. | $435.37 mm | Venture Capital Fund |
New Enterprise Associates 8A, Limited Partnership | $14.05 mm | Venture Capital Fund |
New Enterprise Associates 9, Limited Partnership | $16.94 mm | Venture Capital Fund |
New Enterprise Associates VIII, Limited Partnership | $24.61 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
4
NeueHealth, Inc.
10 Apr 24
SC 13D/A
Mirum Pharmaceuticals, Inc.
29 Dec 23
SC 13D/A
Mirum Pharmaceuticals, Inc.
23 Jun 23
4
Mirum Pharmaceuticals, Inc.
15 Jun 23
4
Akouos, Inc.
2 Dec 22
SC 13D/A
Akouos, Inc.
28 Oct 22
SC 13D
Allakos Inc.
11 Oct 22
SC 13D/A
GENOCEA BIOSCIENCES, INC.
27 May 22
4
GENOCEA BIOSCIENCES, INC.
26 May 22
SC 13D/A
Trevi Therapeutics, Inc.
25 Apr 22
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Apr 24 | New Enterprise Associates 16 | Warrant Common Stock | Buy | Acquire P | No | No | 0.01 | 123,729 | 1.24 k | 123,729 |
13 Jun 23 | New Enterprise Associates 16 | Common Stock | Other | Dispose J | No | No | 0 | 2,000,000 | 0.00 | 2,186,243 |
30 Nov 22 | New Enterprise Associates 16 | Common Stock | Dispose U | No | No | 0 | 4,294,207 | 0.00 | 0 |